Home › Pagkabigo ng Puso › Florida › Miami
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Miami, FL
14 pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Miami (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Nagre-recruitPhase 3
- Research Site, Miami
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Nagre-recruitPhase 3
- University of Miami - Miller School of Medicine, Miami
- Infinite Clinical Research Inc, Miami
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Nagre-recruitPhase 3
- University of Miami, Miami
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Nagre-recruitPhase 3
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Nagre-recruitPhase 3
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Nagre-recruitPhase 3
- CON-10105, Miami, FL, Miami
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Nagre-recruitPhase 3
- Miami, FL Investigative Site 10105, Miami
- Miami, FL Investigative Site 10040, Miami
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Nagre-recruit
- Baptist Health South Florida, Miami
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- Total Research Group LLC, Miami
- Infinite Clinical Research, Miami
- Future Life Clinical Trials, Miami
Assessment of CCM in HF With Higher Ejection Fraction
Nagre-recruit
- Baptist Health South Florida, Miami
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Nagre-recruitPhase 3
- FIN-10105, Miami, FL, Miami
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Nagre-recruit
- Baptist Health South Florida, Miami
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Nagre-recruitPhase 2
- Infinite Clinical Research, Miami
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Nagre-recruitObservasyonal na pag-aaral
- Amavita Clinical Research, Miami
- Advance Medical Research Services Corp (AMRS), Miami
- Baptist Health (Miami Cardiac & Vascular Institute), Miami
Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Dallas, TX42 pag-aaral
- Houston, TX36 pag-aaral
- Cleveland, OH33 pag-aaral
- Chicago, IL31 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- St. Louis, MO26 pag-aaral
- Durham, NC26 pag-aaral
- Kansas City, MO25 pag-aaral
- Atlanta, GA25 pag-aaral
Iba pang pag-aaral sa Miami
- Kanser sa Suso42 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser sa Prostate27 pag-aaral
- Obesity27 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Metastatic Cancer24 pag-aaral
- Kanser sa Ovary23 pag-aaral
- Overweight23 pag-aaral
- Multiple Myeloma21 pag-aaral
- Ulcerative Colitis21 pag-aaral
- Sakit ni Alzheimer20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.